Objective
to report the 2-year clinical outcomes of transcatheter edge-to-edge repair (TEER) + medical therapy or medical therapy alone for the treatment of severe symptomatic tricuspid regurgitation
Study
international randomised study
Population
patients undergoing TEER
Endpoints
1) recurrent heart failure 2) freedom from all-cause death, tricuspid valve surgery and post-treatment visits for 2 years
Conclusion
At 2 years, TEER significantly reduced rates of heart failure and the severity of tricuspid regurgitation compared with medical treatment.
Kar et al. Circulation. 2025 Mar 30.